BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15008361)

  • 1. [Role of endothelin I and angiotensin II in type 2 diabetics with coronary disease].
    Mundo-Sagardía J; Altieri P; Banch H; González R; Escobales N; Crespo M; Rodríguez-Orengo J; Cardona F; Torrado J
    Bol Asoc Med P R; 2003; 95(5):45-50. PubMed ID: 15008361
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for macrovascular disease in type 2 diabetes. Classic lipid abnormalities.
    Steiner G
    Diabetes Care; 1999 Apr; 22 Suppl 3():C6-9. PubMed ID: 10189556
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
    Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglycerides in diabetes: time for action?
    Stewart MW; Laker MF
    Diabet Med; 1994 Oct; 11(8):725-7. PubMed ID: 7851064
    [No Abstract]   [Full Text] [Related]  

  • 5. Sialic Acid, possible marker of angiopathic complications at diabetics type 2.
    Faur L; Motocu M; Moldovan C; Onaca M; Muţiu G
    Rom J Morphol Embryol; 2005; 46(4):307-9. PubMed ID: 16688368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Framingham risk equations underestimate coronary heart disease risk in diabetes.
    Stevens RJ; Coleman RL; Holman RR
    Diabet Med; 2005 Feb; 22(2):228. PubMed ID: 15660747
    [No Abstract]   [Full Text] [Related]  

  • 7. [Risk factors of microangiopathy in patients with non-insulin dependent diabetes mellitus].
    Czech A; Szczeklik Z; Przybyś W
    Pol Tyg Lek; 1996 Jan; 51(1-5):35-6. PubMed ID: 8754299
    [No Abstract]   [Full Text] [Related]  

  • 8. Calculation of coronary risk in Type II diabetes.
    Durrington P
    Clin Sci (Lond); 2001 Dec; 101(6):681-2. PubMed ID: 11724656
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary heart disease in type 2 diabetic patients: common and different risk factors in men and women.
    Lunetta M; Barbagallo A; Attardo T; Crimi S; Sangiorgio L
    Diabetes Metab; 1997 Jun; 23(3):230-1. PubMed ID: 9234001
    [No Abstract]   [Full Text] [Related]  

  • 10. [Markers of vascular inflammation in diabetes mellitus type 2 with hypertension and albuminuria].
    Gómez-Fernández P; Ruiz A; Conde MR; Campos R; Vargas JC; Almaraz M
    Nefrologia; 2004; 24(1):67-9. PubMed ID: 15083960
    [No Abstract]   [Full Text] [Related]  

  • 11. [Our preliminary observations of plasma endothelin behavior in type II diabetes mellitus].
    Bruno CM; Neri S; D'Amico R; Raciti C; Urso G
    Minerva Med; 1996; 87(7-8):331-3. PubMed ID: 8975171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restenosis in diabetic patients: is hyperinsulinemia the culprit?
    Aronson D
    Circulation; 1996 Dec; 94(11):3003-5. PubMed ID: 8941148
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus.
    Mathur G; Noronha B; Rodrigues E; Davis G
    Diabetes Obes Metab; 2007 Sep; 9(5):617-29. PubMed ID: 17697055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension, obesity, diabetes mellitus and ischemic heart disease as syntropy].
    Mel'nikov AIu; Khomenko VL; Sivkov SI; Petrovicheva GV
    Sov Med; 1990; (10):74-7. PubMed ID: 2293394
    [No Abstract]   [Full Text] [Related]  

  • 15. [Endothelin-1 and its role in diabetes mellitus].
    Sármán B; Tóth M; Somogyi A
    Orv Hetil; 1997 Nov; 138(45):2877-81. PubMed ID: 9432637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood fibrinolysis and ischemic disease of the myocardium in diabetes mellitus].
    Barbui T; Di Luzio V; Gambari PF; Previato G; Castellani A
    Cuore Circ; 1969 Apr; 53(2):49-62. PubMed ID: 5403949
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus.
    Zanatta CM; Gerchman F; Burttet L; Nabinger G; Jacques-Silva MC; Canani LH; Gross JL
    Diabetes Res Clin Pract; 2008 May; 80(2):299-304. PubMed ID: 18346810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The angiotensin II inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy].
    Shamkhlova MSh; Trubitsyna NP; Katsaia GV; Goncharov NP; Malysheva NM; Il'in AV; Nikankina LV; Koshel' LV; Shestakova MV
    Ter Arkh; 2008; 80(1):49-52. PubMed ID: 18326228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ischemic heart disease in patients with diabetes mellitus].
    Popov VG; Martynov AI; Martynov IV; Rozova NK; Aksenova GA
    Klin Med (Mosk); 1988 Jan; 66(1):28-34. PubMed ID: 3361810
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticardiolipin and anti-beta2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus.
    Tarkun I; Hacihanefioğlu A; Tarkun P; Cetinarslan B; Cantürk Z
    Diabetes Res Clin Pract; 2005 Jun; 68(3):181-7. PubMed ID: 15936458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.